Paramagnetic contrast agents in magnetic resonance imaging: research at Vanderbilt University.
Experimental studies in animals have demonstrated the application of particulate and chelated paramagnetic oral contrast agents in magnetic resonance imaging (at 0.5 tesla). The ability of a soluble paramagnetic species, ferrous gluconate, to improve imaging studies of the pancreas presently is being evaluated in clinical trials. Two paramagnetic metal ion chelates, Cr EDTA and Gd DTPA, have been evaluated extensively as potential intravascular contrast agents. Renal function, tissue vascularity, abnormalities of the blood-brain barrier, and infarction of myocardial tissue may all be assessed with IV contrast enhanced magnetic resonance imaging. The contrast materials tested all represent first generation compounds. Improved relaxation characteristics, toxicity, distribution, and flexibility will result from development of second generation agents, primarily within the particulate and chelate classes.
D000818:Animals; D003287:Contrast Media; D004285:Dogs; D004353:Drug Evaluation, Preclinical / Q000379:methods; D004492:Edetic Acid / Q000378:metabolism / Q000633:toxicity; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D004369:Pentetic Acid / Q000378:metabolism / Q000633:toxicity; D011817:Rabbits; D012107:Research Design; D014018:Tissue Distribution
D003287:Contrast Media; D004369:Pentetic Acid; D004492:Edetic Acid